New Age Alpha Advisors’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$175K Sell
1,758
-42
-2% -$5.48K 0.01% 639
2025
Q4
$219K Buy
1,800
+4
+0.2% +$502 0.01% 594
2025
Q3
$202K Sell
1,796
-30
-2% -$3.51K 0.01% 634
2025
Q2
$245K Buy
1,826
+113
+7% +$12.4K 0.01% 590
2025
Q1
$115K Sell
1,713
-1,129
-40% -$77.7K 0.01% 726
2024
Q4
$177K Buy
+2,842
New +$265K 0.01% 676

Other funds holding TMDX

New Age Alpha Advisors's TMDX Position: Q1 2026 in Review

New Age Alpha Advisors reduced its Transmedics (TMDX) stake by 2.3% in Q1 2026, selling an estimated $5.48K and leaving 1,758 shares worth $175K. The position accounts for 0.01% of the portfolio, ranked #639.

New Age Alpha Advisors first reported a position in TMDX in Q4 2024 and has held it in 6 quarters since. The position peaked at $245K in Q2 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • New Age Alpha Advisors held 1,758 shares of Transmedics worth $175K as of Q1 2026.
  • New Age Alpha Advisors sold 42 Transmedics shares in Q1 2026, an estimated $5.48K.
  • Transmedics made up 0.01% of New Age Alpha Advisors's portfolio in Q1 2026, its #639 holding.
  • New Age Alpha Advisors first reported a position in Transmedics in Q4 2024 and has held it in 6 quarters since.
  • New Age Alpha Advisors's Transmedics position peaked at $245K in Q2 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on New Age Alpha Advisors's 13F filing for Q1 2026, filed 11 May 2026.